Dynavax Technologies | Passivo Circulante



Current Liabilities Alterar Data
AbbVie USD 38.75B 4.31B 2024-12
Adma Biologics USD 55.54M 10.65M 2024-12
Amgen USD 23.01B 91M 2025-03
AstraZeneca USD 29.13B 1.26B 2025-03
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Dynavax Technologies USD 78.63M 8.6M 2024-12
Gilead Sciences USD 12B 279M 2024-12
Glaxosmithkline GBP 21.7B 238M 2024-12
Merck USD 28.42B 1.17B 2024-12
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
TG Therapeutics USD 90.68M 34.43M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Dynavax Technologies Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.